JPY 1086.0
(0.18%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 6.37 Billion JPY | -1.76% |
2022 | 6.48 Billion JPY | -6.16% |
2021 | 6.91 Billion JPY | -11.69% |
2020 | 7.82 Billion JPY | -12.06% |
2019 | 8.89 Billion JPY | -5.96% |
2018 | 9.46 Billion JPY | 0.45% |
2017 | 9.41 Billion JPY | 16.79% |
2016 | 8.06 Billion JPY | -3.81% |
2015 | 8.38 Billion JPY | -5.99% |
2014 | 8.91 Billion JPY | -4.56% |
2013 | 9.34 Billion JPY | -3.18% |
2012 | 9.65 Billion JPY | 3.87% |
2011 | 9.29 Billion JPY | -5.18% |
2010 | 9.79 Billion JPY | -1.55% |
2009 | 9.95 Billion JPY | 3.73% |
2008 | 9.59 Billion JPY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 1.57 Billion JPY | -3.08% |
2023 Q1 | 1.57 Billion JPY | 1.55% |
2023 Q4 | 1.62 Billion JPY | 2.98% |
2023 Q2 | 1.59 Billion JPY | 1.17% |
2023 Q3 | 1.57 Billion JPY | -0.94% |
2023 FY | 6.37 Billion JPY | -1.76% |
2022 Q3 | 1.58 Billion JPY | -5.4% |
2022 Q4 | 1.55 Billion JPY | -2.28% |
2022 Q1 | 1.67 Billion JPY | 0.04% |
2022 Q2 | 1.67 Billion JPY | 0.42% |
2022 FY | 6.48 Billion JPY | -6.16% |
2021 Q2 | 1.71 Billion JPY | -4.57% |
2021 Q1 | 1.79 Billion JPY | -8.61% |
2021 FY | 6.91 Billion JPY | -11.69% |
2021 Q3 | 1.72 Billion JPY | 0.45% |
2021 Q4 | 1.66 Billion JPY | -3.19% |
2020 Q1 | 1.8 Billion JPY | -14.96% |
2020 FY | 7.82 Billion JPY | -12.06% |
2020 Q4 | 1.96 Billion JPY | -2.28% |
2020 Q3 | 2.01 Billion JPY | -1.0% |
2020 Q2 | 2.03 Billion JPY | 12.62% |
2019 Q2 | 2.33 Billion JPY | 2.76% |
2019 FY | 8.89 Billion JPY | -5.96% |
2019 Q1 | 2.27 Billion JPY | -3.0% |
2019 Q3 | 2.15 Billion JPY | -7.76% |
2019 Q4 | 2.12 Billion JPY | -1.53% |
2018 FY | 9.46 Billion JPY | 0.45% |
2018 Q4 | 2.34 Billion JPY | -0.77% |
2018 Q3 | 2.36 Billion JPY | 2.43% |
2018 Q2 | 2.3 Billion JPY | -5.44% |
2018 Q1 | 2.44 Billion JPY | -63.07% |
2017 Q1 | 954.36 Million JPY | -81.48% |
2017 FY | 9.41 Billion JPY | 16.79% |
2017 Q3 | 925.16 Million JPY | -0.35% |
2017 Q4 | 6.61 Billion JPY | 614.61% |
2017 Q2 | 928.42 Million JPY | -2.72% |
2016 Q4 | 5.15 Billion JPY | 443.11% |
2016 FY | 8.06 Billion JPY | -3.81% |
2016 Q3 | 948.88 Million JPY | -2.94% |
2016 Q2 | 977.61 Million JPY | -0.78% |
2016 Q1 | 985.27 Million JPY | -81.76% |
2015 Q4 | 5.4 Billion JPY | 447.02% |
2015 Q3 | 987.42 Million JPY | 0.67% |
2015 Q2 | 980.83 Million JPY | -3.41% |
2015 Q1 | 1.01 Billion JPY | -82.62% |
2015 FY | 8.38 Billion JPY | -5.99% |
2014 Q4 | 5.84 Billion JPY | 484.75% |
2014 Q2 | 1.01 Billion JPY | -4.85% |
2014 Q1 | 1.06 Billion JPY | -82.97% |
2014 Q3 | 999.41 Million JPY | -1.25% |
2014 FY | 8.91 Billion JPY | -4.56% |
2013 Q4 | 6.24 Billion JPY | 511.78% |
2013 Q1 | 1.03 Billion JPY | -84.22% |
2013 Q2 | 1.04 Billion JPY | 0.2% |
2013 Q3 | 1.02 Billion JPY | -1.89% |
2013 FY | 9.34 Billion JPY | -3.18% |
2012 Q2 | 1.02 Billion JPY | -2.08% |
2012 Q1 | 1.04 Billion JPY | -83.2% |
2012 Q3 | 1 Billion JPY | -1.21% |
2012 Q4 | 6.58 Billion JPY | 553.14% |
2012 FY | 9.65 Billion JPY | 3.87% |
2011 Q3 | 990.79 Million JPY | -4.51% |
2011 Q1 | 1.06 Billion JPY | -83.49% |
2011 Q2 | 1.03 Billion JPY | -2.52% |
2011 FY | 9.29 Billion JPY | -5.18% |
2011 Q4 | 6.19 Billion JPY | 525.71% |
2010 Q1 | 1.14 Billion JPY | -82.52% |
2010 Q2 | 1.12 Billion JPY | -2.3% |
2010 Q3 | 1.08 Billion JPY | -3.69% |
2010 FY | 9.79 Billion JPY | -1.55% |
2010 Q4 | 6.44 Billion JPY | 496.8% |
2009 FY | 9.95 Billion JPY | 3.73% |
2009 Q1 | 1.13 Billion JPY | 0.0% |
2009 Q2 | 1.12 Billion JPY | -1.47% |
2009 Q4 | 6.56 Billion JPY | 481.35% |
2009 Q3 | 1.12 Billion JPY | 0.85% |
2008 FY | 9.59 Billion JPY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Kitanotatsujin Corporation | 9.38 Billion JPY | 32.106% |
Euglena Co., Ltd. | 34.45 Billion JPY | 81.509% |
BEAUTY GARAGE Inc. | 5.8 Billion JPY | -9.832% |
Axas Holdings Co.,Ltd. | 3 Billion JPY | -112.321% |
C.I. Medical Co.,Ltd. | 9 Billion JPY | 29.263% |
Kao Corporation | 438.95 Billion JPY | 98.549% |
Niitaka Co., Ltd. | 6.65 Billion JPY | 4.343% |
Rohto Pharmaceutical Co.,Ltd. | 117.23 Billion JPY | 94.566% |
Shiseido Company, Limited | 696.62 Billion JPY | 99.086% |
Lion Corporation | 160.09 Billion JPY | 96.021% |
Mandom Corporation | 29.51 Billion JPY | 78.412% |
Ivy Cosmetics Corporation | 1.72 Billion JPY | -269.228% |
Milbon Co., Ltd. | 24 Billion JPY | 73.456% |
Nippon Shikizai, Inc. | 2.31 Billion JPY | -175.572% |
Fancl Corporation | 61.61 Billion JPY | 89.661% |
KOSÉ Corporation | 189.85 Billion JPY | 96.645% |
Cota Co., Ltd. | 4.25 Billion JPY | -49.785% |
HABA Laboratories,Inc. | 8.21 Billion JPY | 22.441% |
Pola Orbis Holdings Inc. | 119.68 Billion JPY | 94.677% |
Noevir Holdings Co., Ltd. | 31.54 Billion JPY | 79.802% |
Adjuvant Holdings Co.,Ltd. | 2.86 Billion JPY | -122.619% |
Almado, Inc. | 4.11 Billion JPY | -54.982% |
I-ne CO., LTD. | 17.86 Billion JPY | 64.341% |
Premier Anti-Aging Co., Ltd. | 15.96 Billion JPY | 60.087% |
Liberta Co.,Ltd. | 2.68 Billion JPY | -137.608% |
AXXZIA Inc. | 8.57 Billion JPY | 25.685% |
S.T. Corporation | 15.07 Billion JPY | 57.735% |
Kobayashi Pharmaceutical Co., Ltd. | 70.59 Billion JPY | 90.976% |
Earth Corporation | 57.25 Billion JPY | 88.873% |
Sagami Rubber Industries Co., Ltd. | 1.57 Billion JPY | -305.574% |
Asahi Eito Holdings Co.,Ltd. | 1.29 Billion JPY | -390.624% |
Ya-Man Ltd. | 18.49 Billion JPY | 65.561% |
MTG Co., Ltd. | 33.26 Billion JPY | 80.847% |
TRANSACTION CO.,Ltd. | 4.57 Billion JPY | -39.203% |
SHOBIDO Corporation | 4.5 Billion JPY | -41.556% |
Artnature Inc. | 25.01 Billion JPY | 74.533% |
Pigeon Corporation | 34.72 Billion JPY | 81.655% |
Unicharm Corporation | 351.52 Billion JPY | 98.188% |
Paltac Corporation | 53.06 Billion JPY | 87.994% |
CB GROUP MANAGEMENT Co., Ltd. | 13.78 Billion JPY | 53.786% |